Interestingly, treating lung adenocarcinoma with TGFβ1 suppressed tumor growth and transformation of cell phenotypes by maintaining intracellular actin filament organization; however, treating with activin A did not have the same effect. The gene discussed is TGFB1; the disease is neoplasm.